Systole Health is focused on providing personalized healthcare to women with heart disease. “As a cardiologist, I have witnessed firsthand the struggles women face in managing their heart health," the company's co-founder said.

Multiple studies over the years have linked PVL to an increased risk of adverse outcomes. New research out of Italy, however, suggests that device improvements made by Medtronic, Edwards Lifesciences and Boston Scientific may have reduced PVL's influence.

This is the week of DeepSeek. 

The University of Pennsylvania in Philadelphia has aimed to tackle this conundrum, developing a deep learning-based image analysis tool and AI “orchestrator.” 

Founded in 2019, Evergreen develops and manufactures imaging agents aimed at diagnosing and treating cancer, including Octevy for neuroendocrine tumors. 

The Spain-based company offers a suite of solutions to aid in interpreting MRI, CT, and PET scans, boasting 170 installations across the globe. 

Generative AI has a bright future in medical education. That goes not only for medical schools but also for postgraduate settings in which residents and fellows do most of their learning while also caring for patients.

The cyberattack on University of Missouri Health Care’s systems happened in 2020 and affected 190,000 patients.

The bioresorbable agent is made from small irregularly shaped, dry gelatin particles designed for the embolization of hypervascular tumors and blood vessels. 

Just a small fraction of the people tracking their own heart health are actually doing anything with the data, according to a new survey commissioned by The Ohio State University Wexner Medical Center.